PD-L1 induction in tumor tissue after hypofractionated thoracic radiotherapy for non-small cell lung cancer

We report on a 67-year old male with advanced stage lung adenocarcinoma (initially PD-L1 negative, EGFR and ALK negative) diagnosed in 2014. The patient received 4 lines of palliative chemotherapy from 2014 to 2017, however the disease progressed. In 2015, he also received palliative hypofractionate...

Descripción completa

Detalles Bibliográficos
Autores principales: Narits, Jaanika, Tamm, Hannes, Jaal, Jana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153023/
https://www.ncbi.nlm.nih.gov/pubmed/32300664
http://dx.doi.org/10.1016/j.ctro.2020.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153023/
https://www.ncbi.nlm.nih.gov/pubmed/32300664
http://dx.doi.org/10.1016/j.ctro.2020.04.003

Ejemplares similares